Literature DB >> 27492087

Hydration Free Energy as a Molecular Descriptor in Drug Design: A Feasibility Study.

Ayesha Zafar1, Jóhannes Reynisson2.   

Abstract

In this work the idea was investigated whether calculated hydration energy (ΔGhyd ) can be used as a molecular descriptor in defining promising regions of chemical space for drug design. Calculating ΔGhyd using the Density Solvation Model (SMD) in conjunction with the density functional theory (DFT) gave an excellent correlation with experimental values. Furthermore, calculated ΔGhyd correlates reasonably well with experimental water solubility (r(2) =0.545) and also log P (r(2) =0.530). Three compound collections were used: Known drugs (n=150), drug-like compounds (n=100) and simple organic compounds (n=140). As an approximation only molecules, which do not de/protonate at physiological pH were considered. A relatively broad distribution was seen for the known drugs with an average at -15.3 kcal/mol and a standard deviation of 7.5 kcal/mol. Interestingly, much lower averages were found for the drug-like compounds (-7.5 kcal/mol) and the simple organic compounds (-3.1 kcal/mol) with tighter distributions; 4.3 and 3.2 kcal/mol, respectively. This trend was not observed for these collections when calculated log P and log S values were used. The considerable greater exothermic ΔGhyd average for the known drugs clearly indicates in order to develop a successful drug candidate value of ΔGhyd <-5 kcal/mol or less is preferable.
© 2016 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  B3LYP; chemical space; chemoinformatics and drug design; density solvation model

Mesh:

Substances:

Year:  2016        PMID: 27492087     DOI: 10.1002/minf.201501035

Source DB:  PubMed          Journal:  Mol Inform        ISSN: 1868-1743            Impact factor:   3.353


  7 in total

1.  Theoretical explanation for the pharmaceutical incompatibility through the cooperativity effect of the drug-drug intermolecular interactions in the phenobarbital∙∙∙paracetamol∙∙∙H2O complex.

Authors:  Fei-Peng Zhai; Hong-En Wei; Yi Liu; Feng-Yun Hu
Journal:  J Mol Model       Date:  2019-06-07       Impact factor: 1.810

2.  Approaches for calculating solvation free energies and enthalpies demonstrated with an update of the FreeSolv database.

Authors:  Guilherme Duarte Ramos Matos; Daisy Y Kyu; Hannes H Loeffler; John D Chodera; Michael R Shirts; David L Mobley
Journal:  J Chem Eng Data       Date:  2017-04-24       Impact factor: 2.694

3.  In silico analysis of the antidiabetic terpenoid acankoreagenin binding to PPARγ.

Authors:  Gérard Vergoten; Christian Bailly
Journal:  In Silico Pharmacol       Date:  2021-04-15

4.  Prediction of pKa Values for Neutral and Basic Drugs based on Hybrid Artificial Intelligence Methods.

Authors:  Mengshan Li; Huaijing Zhang; Bingsheng Chen; Yan Wu; Lixin Guan
Journal:  Sci Rep       Date:  2018-03-05       Impact factor: 4.379

5.  Investigation into Improving the Aqueous Solubility of the Thieno[2,3-b]pyridine Anti-Proliferative Agents.

Authors:  Ayesha Zafar; Lisa I Pilkington; Natalie A Haverkate; Michelle van Rensburg; Euphemia Leung; Sisira Kumara; William A Denny; David Barker; Ali Alsuraifi; Clare Hoskins; Jóhannes Reynisson
Journal:  Molecules       Date:  2018-01-11       Impact factor: 4.411

6.  Interaction of obtusilactone B and related butanolide lactones with the barrier-to-autointegration factor 1 (BAF1). A computational study.

Authors:  Christian Bailly; Gérard Vergoten
Journal:  Curr Res Pharmacol Drug Discov       Date:  2021-09-22

7.  Novel Tdp1 Inhibitors Based on Adamantane Connected with Monoterpene Moieties via Heterocyclic Fragments.

Authors:  Aldar A Munkuev; Evgenii S Mozhaitsev; Arina A Chepanova; Evgeniy V Suslov; Dina V Korchagina; Olga D Zakharova; Ekaterina S Ilina; Nadezhda S Dyrkheeva; Alexandra L Zakharenko; Jóhannes Reynisson; Konstantin P Volcho; Nariman F Salakhutdinov; Olga I Lavrik
Journal:  Molecules       Date:  2021-05-24       Impact factor: 4.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.